Annals of Indian Academy of Neurology · 2025
Diffusion Restriction in Wilson's Disease: A Radiological Pointer Toward Clinically Severe Disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garg Divyani, Shah Shariq Ahmad, Agarwal Ayush, Radhakrishnan Divya M, Rajan Roopa, Srivastava Achal Kumar, Garg Ajay
Аннотация
BACKGROUND AND OBJECTIVES: Wilson's disease (WD) is a rare autosomal recessive disorder due to abnormal hepatic copper transport, leading to copper accumulation in the liver, brain, and other tissues. Although conventional magnetic resonance imaging (MRI) features are valuable for diagnosis, the role of diffusion-weighted imaging (DWI) remains underexplored in WD. The study aims to assess the prevalence and clinical correlates of diffusion restriction on MRI in WD.
METHODS: A single-center, retrospective study was conducted. Clinicodemographic and MRI findings of patients diagnosed with WD based on a modified Leipzig score cut-off of 4 were analyzed. Characteristics of patients with diffusion restriction (WD DR+ ) and without diffusion restriction (WD DR- ) were compared using statistical tests.
RESULTS: Of 91 patients with WD, 17 (18.7%) demonstrated MRI diffusion restriction. WD DR+ were noted to have a lower median age at symptom onset (14 [9-17] versus 15 [14-23] years; P = 0.020) and presentation (15 [13-20] years versus 19 [15-25.5] years; P = 0.022) compared to WD DR- . WD DR+ had a higher modified Leipzig score compared to WD DR- (5 [4-5] versus 7 [5-8]; P ≤ 0.001). They also had significantly higher Global Assessment Scale (GAS) for WD (32.5 [30-37]) compared to WD DR- (19 [13-22]) ( P < 0.001). WD DR+ had significantly higher proportions of patients with dysphagia (10/17, 58.8% versus 6/74, 8.1%; P < 0.001) and portal hypertension (8/17, 47.1% versus 6/74, 8.1%; P < 0.001). WD DR+ also experienced significantly higher rates of early neurological deterioration (END) (23.5% versus 6.6%, P = 0.04).
CONCLUSIONS: Diffusion restriction may hence serve as a pointer toward more severe neurological and hepatic involvement in WD, indicating the need for close supervision in this group of patients.
METHODS: A single-center, retrospective study was conducted. Clinicodemographic and MRI findings of patients diagnosed with WD based on a modified Leipzig score cut-off of 4 were analyzed. Characteristics of patients with diffusion restriction (WD DR+ ) and without diffusion restriction (WD DR- ) were compared using statistical tests.
RESULTS: Of 91 patients with WD, 17 (18.7%) demonstrated MRI diffusion restriction. WD DR+ were noted to have a lower median age at symptom onset (14 [9-17] versus 15 [14-23] years; P = 0.020) and presentation (15 [13-20] years versus 19 [15-25.5] years; P = 0.022) compared to WD DR- . WD DR+ had a higher modified Leipzig score compared to WD DR- (5 [4-5] versus 7 [5-8]; P ≤ 0.001). They also had significantly higher Global Assessment Scale (GAS) for WD (32.5 [30-37]) compared to WD DR- (19 [13-22]) ( P < 0.001). WD DR+ had significantly higher proportions of patients with dysphagia (10/17, 58.8% versus 6/74, 8.1%; P < 0.001) and portal hypertension (8/17, 47.1% versus 6/74, 8.1%; P < 0.001). WD DR+ also experienced significantly higher rates of early neurological deterioration (END) (23.5% versus 6.6%, P = 0.04).
CONCLUSIONS: Diffusion restriction may hence serve as a pointer toward more severe neurological and hepatic involvement in WD, indicating the need for close supervision in this group of patients.